The total duration is up to approximately 119 weeks, including a 60-day screening period, a 104-week treatment period, and a 6-week post-treatment safety observation period.
The total duration is up to approximately 119 weeks, including a 60-day screening period, a 104-week treatment period, and a 6-week post-treatment safety observation period.
NCT04221451
Genzyme, a Sanofi Company
19 February 2024
Congrats! You have your own personal workspace now.